Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Comparative Effectiveness Research"
DOI: 10.57264/cer-2024-0092
Abstract: Aim: Estimate the cost-per-remitter with esketamine nasal spray plus an oral antidepressant (ESK NS + OAD) versus quetiapine extended release plus an oral antidepressant (QTP XR + OAD) among adults with treatment-resistant depression (TRD). Materials… read more here.
Keywords: oad; treatment; cost per; per remitter ... See more keywords